Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 110 (4), 267-9

Occurrence of Beta-Methylamino-L-Alanine (BMAA) in ALS/PDC Patients From Guam

Affiliations

Occurrence of Beta-Methylamino-L-Alanine (BMAA) in ALS/PDC Patients From Guam

S J Murch et al. Acta Neurol Scand.

Abstract

We tested the brain tissues of the Chamorro people of Guam who died of amyotrophic lateral sclerosis/Parkinsonism dimentia complex (ALS/PDC) for the neurotoxin beta-methylamino-l-alanine (BMAA). We used validated high-pressure liquid chromatography and liquid chromatography-mass spectrometry analyses to test well-characterized archival tissues of the superior frontal gyrus from eight Chamorros from Guam and a comparison group of 15 Canadians. BMAA was found as a free amino acid in 83% of Chamorro ALS/PDC patients (3-10 microg/g) as a protein-associated amino acid in 100% of the Chamorro individuals (149-1190 microg/g). Both forms of BMAA were also found at comparable levels in two Canadians who died of progressive neurodegenerative disease. BMAA, which is produced by cyanobacteria, may be associated with some cases of neurodegenerative disease.

Similar articles

See all similar articles

Cited by 71 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback